ASX:SPL (Australia)  
Starpharma Holdings Ltd logo

Starpharma Holdings Ltd

A$ 0.51 (-3.81%) Dec 9
P/E:
At Loss
P/B:
4.45
Market Cap:
A$ 214.65M ($ 145.85M)
Enterprise V:
A$ 172.92M ($ 117.50M)
Volume:
312.21K
Avg Vol (2M):
223.34K
Also Trade In:
Volume:
312.21K
Market Cap A$:
214.65M
Market Cap $:
145.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
223.34K
Enterprise Value A$:
172.92M
Enterprise Value $:
117.50M
PB Ratio:
4.45

Business Description

Description
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.